RenaCare Dialysis Clinic Business Plan › Section 15 › Conclusion

Renacare Dialysis Clinic (Pty) Ltd represents an attractive,
defensible healthcare investment opportunity in a market characterised
by structural excess demand, regulatory protection, and manageable
operational complexity. The R20 million funding requirement supports a
business plan projected to generate R57.9 million of annual revenue,
R22.5 million of EBITDA and a 22.4% project-level IRR by Year 5 —
returns that compare favourably both to sector comparables and to South
African private equity benchmarks.

The investment case rests on three pillars. First, demand is
structural and growing. The South African Renal Registry documents a
sustained gap between ESRD incidence and treatment capacity that will
not close under current trajectories; Renacare’s flagship clinic will
meaningfully contribute to this gap. Second, the business model is
proven. National Renal Care and Life Renal Dialysis have validated at
scale that 20-station clinics generate predictable, annuity-like
revenues at attractive margins; Renacare’s financial model takes this
validation and applies disciplined cost control and focused execution.
Third, the management team combines the three skill sets needed to
deliver — clinical excellence through the Medical Director, operational
rigour through the Head of Nursing and Managing Director, and financial
and capital-markets discipline through the CFO and Board.

The risks to the plan are real but manageable. Medical-aid tariff
compression, nurse workforce constraints, and the longer-term
uncertainty of National Health Insurance implementation together
represent the principal exogenous threats. In each case mitigation
strategies are identified, resourced and assigned to named accountable
executives. The internal risks — principally execution risk on a complex
build programme and ramp-up risk during the first 18 months of
operations — are addressed through disciplined project governance,
phased soft launch, and contingency funding in the form of an undrawn R3
million working-capital facility.

Renacare invites prospective investors, lenders and strategic
partners to engage further on this opportunity. Detailed financial
models, clinical protocol documentation, site feasibility studies and
management biographies are available to qualifying counterparties under
appropriate confidentiality protection.

Confidential — this business plan is provided to prospective investors and lenders for evaluation purposes only and may not be reproduced or distributed without the written consent of RenaCare Dialysis Clinic (Pty) Ltd.